The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.
about
PSK, a novel STE20-like kinase derived from prostatic carcinoma that activates the c-Jun N-terminal kinase mitogen-activated protein kinase pathway and regulates actin cytoskeletal organizationSerglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitroConcerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motilityChanges in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerMatrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesionA role for chemokine receptor transactivation in growth factor signaling.The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism.Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomicsMatrix metalloproteinase-9 contributes to choroidal neovascularization.Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitorsTemporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation.Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Study of matrix metalloproteinases and their inhibitors in prostate cancer.Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Matrix metalloproteinases in tumorigenesis: an evolving paradigm.Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model.Enzyme-mediated individual nanoparticle release assay.Genetic characterization of vocal fold lesions: leukoplakia and carcinoma.Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9Study of matrix metalloproteinases and their inhibitors in breast cancer.Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein sheddingEstablishment and maintenance of cell polarity during leukocyte chemotaxisDisease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesProteolytic factors in exosomes.Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.Metastasis review: from bench to bedside.A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.Insulin-like Growth Factor Binding Protein-3 expression in the human corneal epithelium.Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-II via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix.Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface.Inflammation and cancer.Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells.Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway.
P2860
Q22011202-50F6BD41-7B94-4C8C-AE6E-54F57AD6A671Q24298121-2555A46E-7AB0-4892-B2B0-C7223383251BQ24554511-887A1796-A2BF-4371-8F71-0D011E64E075Q24807354-E72B0980-D749-4298-84EC-8D379AF2E340Q28214421-B57D09F0-FAD6-4EE4-ADB2-682187C73F7AQ28282509-5BD3BAE8-0AA0-4EBD-B615-DE2166EA9BF1Q28360845-C93CA74B-74A6-4F4E-ADCB-AE7F9CFAD296Q28365928-E79C527F-A3B6-44CA-8908-2DF03BB35B4EQ30387118-43775DE0-69F9-421D-B043-D51AC7094123Q30860298-BDFF132E-2B74-46A7-9546-615BB123A46CQ33338236-C9318787-977E-4F2A-B64F-739A79460447Q33371165-12DC391A-4BA5-4CB6-9061-C4C14F7EB5E4Q33569159-F98B1D36-EB02-487A-B514-F563F0713AEAQ33708162-71662359-ADD9-4A69-A7F4-2342A173B6D1Q33890792-9D03B776-BF7C-4C10-9367-A45224341EF6Q34199345-E39D0217-42B5-4D77-AEA0-66F35478EA96Q34473935-0B816D7A-1F5C-4617-A4D4-699BBA3C4931Q35103092-56212089-191C-4132-83EF-7664475369D9Q35757808-E351CDF5-348D-4D46-81DC-3294E450B232Q36076371-11391A1C-D4D3-44A7-9F9C-5EE36CC4E033Q36086653-AA147DCF-AF32-4DE4-BA55-5B878D807581Q36610142-380FA178-0DE3-47E1-8493-461D67319038Q36611308-BE0134CD-E381-480B-8EBD-8302DE813E3DQ36804675-D2B7A51F-C024-40E3-97B7-18E2C09F6EE7Q37079866-09D8B88B-444C-4E65-B177-AA282C8CF66BQ37418923-8C3C622A-82B7-4802-A06D-4A91CDA06287Q37589790-6358BA05-FC53-4FAE-A650-A875BD794193Q38092801-273AB6A7-B16B-4F4A-9E3E-71B215ADC118Q38224605-0E890509-0A5D-4721-8D4D-2867D52543DAQ38237985-EAF1BEE9-3252-4858-B875-2FCA13EFD974Q38348323-1625DB66-5913-48EA-A2AF-50D3C58E2AA0Q38836952-9669E620-DB9E-4DFA-898D-7C40E40118B1Q40091510-DC35BD03-6A80-4538-8111-97DD3BAE0923Q40159420-569ACD0F-DD34-421C-8B75-195282AE1992Q40195910-E306C472-002E-4063-B5FF-5C448F7E3D99Q40526648-40806A5D-A553-4121-BCFD-7F200CE55A2BQ40568311-F38BB914-B013-4CA1-A271-E2E8B54E6F03Q41853728-BE2847C3-84B5-473E-8278-2FC43E0B8CA3Q42917821-183732C8-DE19-44D4-BD27-6D19086B0814Q43060191-93DC0758-961B-4B6D-835A-0FFF4F3AA6A2
P2860
The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
The matrix metalloproteinase-9 ...... nse in DU-145 carcinoma cells.
@en
type
label
The matrix metalloproteinase-9 ...... nse in DU-145 carcinoma cells.
@en
prefLabel
The matrix metalloproteinase-9 ...... nse in DU-145 carcinoma cells.
@en
P2093
P2860
P356
P1476
The matrix metalloproteinase-9 ...... nse in DU-145 carcinoma cells.
@en
P2093
Gómez-Moutón C
Lacalle RA
Llorente M
Martínez-A C
P2860
P304
P356
10.1074/JBC.274.11.6935
P407
P577
1999-03-01T00:00:00Z